MADISON, N.J., Oct. 21, 2015 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that its ExamOne business, the leader in helping insurers meet their underwriting needs, has agreed to acquire the business assets of Superior Mobile Medics.
Based in San Diego, Calif., Superior Mobile Medics is a national provider of paramedical and health data collection services to the life insurance and employer health and wellness industries with 20 years of growing market presence. Upon completion of the acquisition, Superior Mobile Medics' life insurance clients will continue to enjoy the high levels of customer service they receive today, and will have access to ExamOne's broad menu of innovative services, including laboratory testing, information and call center services and ExamOne's network of nearly 700 paramedical service centers. Superior's Health Solutions clients will also benefit from Quest's unmatched expertise in the wellness industry.
"We are excited about the opportunity to expand our capabilities to customers," said Cathy Doherty, Senior Vice President, Clinical Franchises, Quest Diagnostics. "The insights provided by ExamOne enable customers to make important decisions for a family's future. Investing in this segment of the market combines two companies that are dedicated to quality, service and innovation and will significantly enhance customer access and service."
ExamOne and Superior Mobile Medics expect to complete the transaction in the fourth quarter of 2015. Financial terms were not disclosed.
About Quest Diagnostics
Quest Diagnostics is the world's leading provider of diagnostic information services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic information services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at QuestDiagnostics.com. Follow us at Facebook.com/QuestDiagnostics and Twitter.com/QuestDX.
Denny Moynihan, Quest Diagnostics (Media): 973-520-2800
Dan Haemmerle, Quest Diagnostics (Investors): 973-520-2900
SOURCE Quest Diagnostics